Novartis to Conduct Clinical Trial of Hydroxychloroquine on Covid-19 Patients
The clinical trial complements a commitment by Novartis to donate up to 130 million tablets of hydroxychloroquine to global clinical research efforts.
(Picture: Deposit Photos)
1/1 Back to the Article